Literature DB >> 4018066

Etiology of community-acquired pneumonia in patients requiring hospitalization.

E Berntsson, J Blomberg, T Lagergård, B Trollfors.   

Abstract

The etiology of community-acquired pneumonia was studied in 127 patients with roentgenologically verified pneumonia who needed hospitalization. Etiology was determined on the basis of a positive blood culture and/or a significant antibody titer increase. Streptococcus pneumoniae was the probable etiological agent in 69 patients, nontypeable Haemophilus influenzae in five patients, Streptococcus pyogenes in two patients, and Legionella pneumophila and Staphylococcus aureus in one patient each. Evidence of Mycoplasma pneumoniae infection was found in 18 patients and of Chlamydia psittaci infection in three patients. Influenza virus type A was the cause of infection in 15 patients. One patient had infection with influenza virus type B, one patient with parainfluenza virus type 1, and three patients with respiratory syncytial virus. In 20 patients there was evidence of infection with more than one microorganism. No etiological agent was found in 27 patients. Since Streptococcus pneumoniae was the predominant etiological agent penicillin should be drug of first choice in patients with pneumonia who need treatment in hospital. In young adults, however, the high frequency of Mycoplasma pneumoniae infection would justify the use of erythromycin or doxycycline as drug of first choice.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4018066     DOI: 10.1007/bf02013650

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN: 0722-2211            Impact factor:   3.267


  19 in total

1.  Application of a microtechnique to viral serological investigations.

Authors:  J L SEVER
Journal:  J Immunol       Date:  1962-03       Impact factor: 5.422

2.  Counter-current immunoelectrophoresis for the diagnosis of pneumococcal chest infection.

Authors:  M El-Refaie; C Dulake
Journal:  J Clin Pathol       Date:  1975-10       Impact factor: 3.411

3.  The role of viruses, mycoplasmas and bacteria in acute pneumonia in civilian adults.

Authors:  M A Mufson; V Chang; V Gill; S C Wood; M J Romansky; R M Chanock
Journal:  Am J Epidemiol       Date:  1967-11       Impact factor: 4.897

4.  Detection by immunoelectrophoresis of antigen in sera of patients with pneumococcal bacteraemia.

Authors:  G J Dorff; J D Coonrod; M W Rytel
Journal:  Lancet       Date:  1971-03-20       Impact factor: 79.321

5.  Streptococcal anti-desoxyribonuclease B: microtechnique determination.

Authors:  J Nelson; E M Ayoub; L W Wannamaker
Journal:  J Lab Clin Med       Date:  1968-05

6.  Transtracheal aspiration in the evaluation of patients with pneumonia.

Authors:  H H Hahn; H N Beaty
Journal:  Ann Intern Med       Date:  1970-02       Impact factor: 25.391

7.  Etiologies and characteristic features of pneumonias in a municipal hospital.

Authors:  G J Dorff; M W Rytel; S G Farmer; G Scanlon
Journal:  Am J Med Sci       Date:  1973-11       Impact factor: 2.378

8.  Causes of pneumonia presenting to a district general hospital.

Authors:  R J White; A D Blainey; K J Harrison; S K Clarke
Journal:  Thorax       Date:  1981-08       Impact factor: 9.139

9.  Serological diagnosis of pneumococcal disease with enzyme-linked immunosorbent assay (ELISA).

Authors:  E Berntsson; K A Broholm; B Kaijser
Journal:  Scand J Infect Dis       Date:  1978

10.  Legionnaires' disease: description of an epidemic of pneumonia.

Authors:  D W Fraser; T R Tsai; W Orenstein; W E Parkin; H J Beecham; R G Sharrar; J Harris; G F Mallison; S M Martin; J E McDade; C C Shepard; P S Brachman
Journal:  N Engl J Med       Date:  1977-12-01       Impact factor: 91.245

View more
  25 in total

1.  BTS Guidelines for the Management of Community Acquired Pneumonia in Adults.

Authors: 
Journal:  Thorax       Date:  2001-12       Impact factor: 9.139

2.  Guidelines for the management of adult lower respiratory tract infections--full version.

Authors:  M Woodhead; F Blasi; S Ewig; J Garau; G Huchon; M Ieven; A Ortqvist; T Schaberg; A Torres; G van der Heijden; R Read; T J M Verheij
Journal:  Clin Microbiol Infect       Date:  2011-11       Impact factor: 8.067

3.  Aetiology of community-acquired pneumonia: a prospective study among adults requiring admission to hospital.

Authors:  R Bohte; R van Furth; P J van den Broek
Journal:  Thorax       Date:  1995-05       Impact factor: 9.139

4.  Early recognition of Streptococcus pneumoniae in patients with community-acquired pneumonia.

Authors:  R Bohte; J Hermans; P J van den Broek
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-03       Impact factor: 3.267

5.  Etiology of community-acquired pneumonia in out-patients.

Authors:  E Berntsson; T Lagergård; O Strannegård; B Trollfors
Journal:  Eur J Clin Microbiol       Date:  1986-08       Impact factor: 3.267

6.  Antibiotic treatment in pneumonia due to Q fever.

Authors:  V Sobradillo; R Zalacain; A Capelastegui; F Uresandi; J Corral
Journal:  Thorax       Date:  1992-04       Impact factor: 9.139

7.  Pneumonia due to Branhamella catarrhalis.

Authors:  S Capewell; D T McLeod; M J Croughan; F Ahmad; M A Calder; A Seaton
Journal:  Thorax       Date:  1988-11       Impact factor: 9.139

8.  Ampicillin versus cefamandole as initial therapy for community-acquired pneumonia.

Authors:  D J Weber; S B Calderwood; A W Karchmer; J E Pennington
Journal:  Antimicrob Agents Chemother       Date:  1987-06       Impact factor: 5.191

9.  Community acquired pneumonia: aetiology and prognostic index evaluation.

Authors:  N C Karalus; R T Cursons; R A Leng; C B Mahood; R P Rothwell; B Hancock; S Cepulis; M Wawatai; L Coleman
Journal:  Thorax       Date:  1991-06       Impact factor: 9.139

10.  Mycoplasma pneumoniae pneumonia revisited within the German Competence Network for Community-acquired pneumonia (CAPNETZ).

Authors:  Heike von Baum; Tobias Welte; Reinhard Marre; Norbert Suttorp; Christian Lück; Santiago Ewig
Journal:  BMC Infect Dis       Date:  2009-05-13       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.